Old gout drug tested as new hope for COVID-19 recovery
NCT ID NCT06847204
Summary
This study tested whether colchicine, a common and affordable anti-inflammatory drug used for gout, could help patients with mild-to-moderate COVID-19 pneumonia. Researchers gave the drug to 66 hospitalized patients to see if it could shorten their hospital stay and reduce their need for supplemental oxygen. The goal was to find a low-cost treatment option, especially for areas where expensive COVID-19 drugs are hard to get.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General hospital
Lahore, Punjab Province, Pakistan
Conditions
Explore the condition pages connected to this study.